These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 34093179)

  • 21. Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice.
    Schiavon AP; Bonato JM; Milani H; Guimarães FS; Weffort de Oliveira RM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():27-34. PubMed ID: 26187374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabidiol and Other Cannabinoids: From Toxicology and Pharmacology to the Development of a Regulatory Pathway.
    Koturbash I; MacKay D
    J Diet Suppl; 2020; 17(5):487-492. PubMed ID: 32715797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview.
    Mandolini GM; Lazzaretti M; Pigoni A; Oldani L; Delvecchio G; Brambilla P
    Epidemiol Psychiatr Sci; 2018 Aug; 27(4):327-335. PubMed ID: 29789034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
    Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
    Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
    Melas PA; Scherma M; Fratta W; Cifani C; Fadda P
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabidiol: pharmacology and therapeutic targets.
    Britch SC; Babalonis S; Walsh SL
    Psychopharmacology (Berl); 2021 Jan; 238(1):9-28. PubMed ID: 33221931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms.
    Silote GP; Sartim A; Sales A; Eskelund A; Guimarães FS; Wegener G; Joca S
    J Chem Neuroanat; 2019 Jul; 98():104-116. PubMed ID: 31039391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle.
    Gonzalez-Cuevas G; Martin-Fardon R; Kerr TM; Stouffer DG; Parsons LH; Hammell DC; Banks SL; Stinchcomb AL; Weiss F
    Neuropsychopharmacology; 2018 Sep; 43(10):2036-2045. PubMed ID: 29686308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus.
    Luján MÁ; Castro-Zavala A; Alegre-Zurano L; Valverde O
    Neuropharmacology; 2018 Dec; 143():163-175. PubMed ID: 30273593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol and brain function: current knowledge and future perspectives.
    Schouten M; Dalle S; Mantini D; Koppo K
    Front Pharmacol; 2023; 14():1328885. PubMed ID: 38288087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
    Khalid S; Almalki FA; Hadda TB; Bader A; Abu-Izneid T; Berredjem M; Elsharkawy ER; Alqahtani AM
    Curr Pharm Des; 2021; 27(13):1564-1578. PubMed ID: 33267756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of drug class on reward in substance use disorders.
    Jones JD; Arout CA; Luba R; Murugesan D; Madera G; Gorsuch L; Schusterman R; Martinez S
    Pharmacol Biochem Behav; 2024 Jul; 240():173771. PubMed ID: 38670466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage.
    Hurd YL; Yoon M; Manini AF; Hernandez S; Olmedo R; Ostman M; Jutras-Aswad D
    Neurotherapeutics; 2015 Oct; 12(4):807-15. PubMed ID: 26269227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cannabidiol treatment in an adolescent with multiple substance abuse, social anxiety and depression.
    Laczkovics C; Kothgassner OD; Felnhofer A; Klier CM
    Neuropsychiatr; 2021 Mar; 35(1):31-34. PubMed ID: 32052321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence.
    Prud'homme M; Cata R; Jutras-Aswad D
    Subst Abuse; 2015; 9():33-8. PubMed ID: 26056464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
    Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
    Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
    Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.